Filing Flows › Longevity Health Holdings (XAGE) › Q1 2025
Longevity Health Holdings (XAGE) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 15, 2025
Longevity Health Holdings (XAGE) reported revenue of $510K for the first quarter 2025 (Q1 2025) and up 29-fold from the quarter before. Operating margin was -295.2%, net loss $1.5M (295.1% of revenue).
Longevity Health Holdings, Q1 2025: revenue $510K, operating margin -295.2%, net loss $1.5M, operating cash flow −$753K. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $510K | 29× | — |
| Operating profit | −$1.5M | — | — |
| Net earnings | −$1.5M | — | — |
| Operating cash flow | −$753K | — | — |
What changed
Revenue was $510K in Q1 2025, up 2820% from the previous quarter.
Gross margin was 52.9%. Operating costs exceeded revenue by $1.5M, an operating margin of -295.2%. The quarter ended with a net loss of $1.5M, wider than the previous quarter's $914K loss.
Operating cash flow was −$753K. Non-cash charges added back $24K of depreciation and amortization and $115K of share-based compensation. Working capital and other items added $614K.
Questions
What was Longevity Health Holdings' revenue in the first quarter 2025?
Longevity Health Holdings (XAGE) reported revenue of $510K for the first quarter 2025 (Q1 2025) and up 29-fold from the quarter before.
Was Longevity Health Holdings profitable in the first quarter 2025?
Operating loss was $1.5M (-295.2% of revenue) and net loss $1.5M.